Established with a clear mission, AIS Healthcare stands out as a multifaceted company striving to do more for patients and providers. The institution is focused on advancing medical experiences through cutting-edge solutions that have allowed its evolution as a comprehensive provider of targeted drug delivery (TDD) and infusion care services.
The company is licensed in 50 states and is home to advanced 503A pharmacies in Ridgeland and Dallas, which gives rise to targeted drug delivery prescriptions that are specific, situated in five locations that offer the latest infusion care, which includes but are not limited to Birmingham, Panama City, Dallas, Valdosta, and Clinton.
Executive Leadership
At the helm of its success is a team of visionary leaders such as Jud Hall, Michelle Wiest, and Cindy Dumas, who understand the significance of patient-centered care under the leadership of CEO Simon Castellanos, whose ethos of superseding expectations permeates the entire organization.
Targeted Drug Delivery (TDD)
The company is recognized for its expertise in targeted drug delivery (TDD), an innovative pain management and treatment approach. This methodology involves delivering medications directly into the spinal canal, providing a highly effective way to manage severe chronic pain and spasticity. TDD has emerged as a safer alternative to traditional oral opioids, significantly reducing the risk of overdose or abuse.
Advanced Infusion Care (AIC)
Advanced Infusion Care (AIC), a division of AIS Healthcare, specializes in providing top-tier in-home infusion services. Supported by multiple locations across the United States, AIC offers patients a range of infusion therapies, ensuring their well-being and comfort is well catered for.
The compassionate and skilled team at AIC, including; clinical pharmacists, infusion nurse specialists, and intake managers, are all dedicated to offering personalized care and 24/7 support.
A dream was realized by reopening a new pharmacy in Valdosta comprising 40 licensed professionals and serving more than 1400 patients, thus supporting persons with various immunodeficiency’s and ailments such as multiple sclerosis and brain injuries.
Accreditation
AIS’s commitment to excellence is reinforced by its dual accreditation from URAC (Utilization Review Accreditation Commission) and the Accreditation Commission for Health Care (ACHC). These prestigious accreditations validate the company’s dedication to meeting industry standards, ensuring patient safety, and maintaining exceptional quality throughout its operations.